Bristol-Myers Squibb Credit Agreements

29 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Amendment to Five Year Competitive Advance and Revolving Credit Facility Agreement among Bristol-Myers Squibb Company, Lenders, and Administrative Agents (June 22, 2021)
Credit Agreements
Bristol-Myers Squibb
Pharmaceuticals
NY
2021
Extension Notice for Five Year Competitive Advance and Revolving Credit Facility Agreement between Bristol-Myers Squibb Company and Citibank, N.A.
Credit Agreements
Bristol-Myers Squibb
Pharmaceuticals
2021
Amendment and Waiver to Five Year Competitive Advance and Revolving Credit Facility Agreement (Bristol-Myers Squibb, JPMorgan Chase, Citibank, and Lenders)
Credit Agreements
Bristol-Myers Squibb
Pharmaceuticals
NY
2021
Extension Notice for Revolving Credit Facility between Bristol-Myers Squibb Company and Citibank, N.A.
Credit Agreements
Bristol-Myers Squibb
Pharmaceuticals
2021
Amendment to Five Year Competitive Advance and Revolving Credit Facility Agreement among Bristol-Myers Squibb Company, Lenders, and Administrative Agents (January 22, 2021)
Credit Agreements
Bristol-Myers Squibb
Pharmaceuticals
NY
2021
Amendment to Five Year Competitive Advance and Revolving Credit Facility Agreement – Bristol-Myers Squibb Company, Lenders, and Administrative Agents
Credit Agreements
Bristol-Myers Squibb
Pharmaceuticals
NY
2021
Amendment and Waiver to Five Year Competitive Advance and Revolving Credit Facility Agreement among Bristol-Myers Squibb Company, Lenders, and Administrative Agents
Credit Agreements
Bristol-Myers Squibb
Pharmaceuticals
NY
2020
Amendment and Waiver to Five Year Competitive Advance and Revolving Credit Facility Agreement among Bristol-Myers Squibb Company, Citibank, JPMorgan Chase, and Other Lenders (June...
Credit Agreements
Bristol-Myers Squibb
Pharmaceuticals
NY
2020
Amendment and Waiver to Five Year Competitive Advance and Revolving Credit Facility Agreement among Bristol-Myers Squibb Company and Lenders (June 20, 2019)
Credit Agreements
Bristol-Myers Squibb
Pharmaceuticals
NY
2019
Amendment to 2012 Credit Agreement among Bristol-Myers Squibb Company and Lenders (June 26, 2017)
Credit Agreements
Bristol-Myers Squibb
Pharmaceuticals
VA
2017
Bristol-Myers Squibb Company Extension Notice for 2012 Credit Agreement with Citibank, N.A.
Credit Agreements
Bristol-Myers Squibb
Pharmaceuticals
2015
Extension Notice for 2011 Credit Agreement between Bristol-Myers Squibb Company and Citibank, N.A.
Credit Agreements
Bristol-Myers Squibb
Pharmaceuticals
2015
Extension Notice for 2012 Credit Agreement between Bristol-Myers Squibb Company and Citibank, N.A.
Credit Agreements
Bristol-Myers Squibb
Pharmaceuticals
2014
Extension Notice for 2011 Credit Agreement between Bristol-Myers Squibb Company and Citibank, N.A.
Credit Agreements
Bristol-Myers Squibb
Pharmaceuticals
2014
Extension Letter to Five Year Competitive Advance and Revolving Credit Facility Agreement between Bristol-Myers Squibb Company and Citibank, N.A.
Credit Agreements
Bristol-Myers Squibb
Pharmaceuticals
2013
Extension Letter to Credit Agreement between Bristol-Myers Squibb Company and Citibank, N.A. (June 3, 2013)
Credit Agreements
Bristol-Myers Squibb
Pharmaceuticals
2013
Extension Notice for Revolving Credit Facility Agreement between Bristol-Myers Squibb Company and Citibank, N.A.
Credit Agreements
Bristol-Myers Squibb
Pharmaceuticals
2021
Extension Notice for Five Year Competitive Advance and Revolving Credit Facility Agreement between Bristol-Myers Squibb Company and Citibank, N.A.
Credit Agreements
Bristol-Myers Squibb
Pharmaceuticals
2021
$4,000,000,000 Term Loan Credit Agreement among Bristol-Myers Squibb Company, Lenders, Citibank, N.A., and JPMorgan Chase Bank, N.A. (November 4, 2020)
Credit Agreements
Bristol-Myers Squibb
Pharmaceuticals
NY
2020
Extension Notice for Revolving Credit Facility Agreement between Bristol-Myers Squibb Company and Citibank, N.A.
Credit Agreements
Bristol-Myers Squibb
Pharmaceuticals
2019
Extension Notice for Revolving Credit Facility between Bristol-Myers Squibb Company and Citibank, N.A.
Credit Agreements
Bristol-Myers Squibb
Pharmaceuticals
2019
3-Year $1,000,000,000 Revolving Credit Facility Agreement among Bristol-Myers Squibb Company, Borrowing Subsidiaries, and Lenders
Credit Agreements
Bristol-Myers Squibb
Pharmaceuticals
NY
2019
364-Day $2 Billion Revolving Credit Facility Agreement among Bristol-Myers Squibb Company, Borrowing Subsidiaries, and Lenders
Credit Agreements
Bristol-Myers Squibb
Pharmaceuticals
NY
2019
Extension Letter for Five Year Competitive Advance and Revolving Credit Facility Agreement between Bristol-Myers Squibb Company and Citibank, N.A.
Credit Agreements
Bristol-Myers Squibb
Pharmaceuticals
2018
Bristol-Myers Squibb Company Extension Letter for Five Year Competitive Advance and Revolving Credit Facility Agreement with Citibank, N.A.
Credit Agreements
Bristol-Myers Squibb
Pharmaceuticals
2018
First Amendment to Five Year Competitive Advance and Revolving Credit Facility Agreement among Bristol-Myers Squibb Company and Lenders
Credit Agreements
Bristol-Myers Squibb
Pharmaceuticals
VA
2013
$1,500,000,000 Five Year Competitive Advance and Revolving Credit Facility Agreement among Bristol-Myers Squibb Company, Borrowing Subsidiaries, and Lenders
Credit Agreements
Bristol-Myers Squibb
Pharmaceuticals
DE
2012
Five Year $1.5 Billion Competitive Advance and Revolving Credit Facility Agreement among Bristol-Myers Squibb Company, Borrowing Subsidiaries, and Lenders
Credit Agreements
Bristol-Myers Squibb
Pharmaceuticals
NY
2011
Five-Year $500,000,000 Competitive Advance and Revolving Credit Facility Agreement among Bristol-Myers Squibb Company, Borrowing Subsidiaries, and Lenders
Credit Agreements
Bristol-Myers Squibb
Pharmaceuticals
NY
2003